In the past decades, the face of childhood diabetes has changed, and type 2 diabetesFrarely seen before at this ageFis appearing and becoming predominant, particularly in African Americans, American Indians and Latino children. To gain insights into the pathophysiology of type 2 DM (T2DM) in youth, we studied obese children and adolescents with impaired glucose tolerance (IGT). The specific aims were: (a) to determine the relative roles of insulin resistance and beta cell dysfunction in the early stage of the development of T2DM in youth; (b) to assess whether altered partitioning of myocellular and abdominal fat is related to abnormalities in glucose metabolism in obese adolescents with IGT; and (c) to determine the impact of different degrees of the metabolic syndrome in obese children and adolescents.
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Methods
We combined the hyperinsulinemic-euglycemic clamp with stable isotopes infusion, indirect calorimetry, and the hyperglycemic clamp in adolescents with NGT and IGT who were well matched for age, and total body fat.
1 H-NMR and MRI techniques were used to noninvasively quantify skeletal muscle and abdominal fat partitioning.
In a large cohort of 439 obese children and adolescents, we studied the prevalence of the metabolic syndrome. Eligibility criteria included age between 4 and 20 years, BMI greater than 97th percentile for age and gender and otherwise healthy. Exclusion criteria were known diabetes or taking any medication that alters blood pressure, glucose or lipid metabolism. Youth on chronic anti-inflammatory medications were also excluded. In total, 20 nonobese (BMIo85th-percentile) and 31 overweight (85th percentile 4BMIo97th percentile) siblings of obese subjects were recruited to serve as comparison groups.
All subjects underwent a standard 75 g oral glucose test. Baseline measures included plasma lipids, CRP, IL-6 and adiponectin levels. Body weight and height were measured and body mass index (BMI) was calculated. Blood pressure was measured in triplicate in the semirecumbent position.
Definitions
Criteria we used for diagnosing MS are a modification of the NCP ATP and WHO criteria. Since body proportions normally change dramatically during pubertal development and may vary between ethnic groups, differences in waist circumference are difficult to interpret in children. We elected instead to define obesity based on a threshold of BMI Z-score 42, adjusted for age and gender. Subjects were then divided into 'moderately obese' (2rBMI-Zr2.5) and 'severely obese' (BMI-Z42.5). Elevated systolic or diastolic blood pressure and abnormalities in fasting triglycerides and HDL-C were defined using reference values from the Princeton School Study and the NHLBI Growth and Health Study (NGHS). IGT was defined as a 2-h glucose 4140 and o200 mg/dl. As in adults, subjects in this study were classified as having the MS when they met three or more of the following criteria:
BMI 497th percentile for age and gender (BMI Z-score 42). Triglycerides 495th percentile for age, gender. HDL-C o5th percentile for age, gender. Systolic blood pressure and/or diastolic blood pressure 495% percentile for age and gender. Impaired glucose tolerance.
Insulin sensitivity was determined by the homeostatic model assessment (HOMA-IR).

Results
This study demonstrated novel insights into the pathogenesis of IGT in obese youth, namely that obese adolescents with IGT have: (a) profound peripheral insulin resistance with major defects in nonoxidative glucose metabolism; (b) increased intramyocellular lipid accumulation along with visceral fat mass which are related to insulin resistance; (c) normal insulin suppression of total body fat oxidation, FFA levels and glycerol turnover; (d) no compensatory increases in insulin secretion; (e) low adiponectin levels.
The prevalence of the MS increased with the severity of obesity and reached more than 50% in severely obese youngsters vs 39% in moderately obese; none of the overweight or nonobese subjects met the criteria. To test the effect of increasing insulin resistance, the cohort was divided by HOMA-IR tertiles using the 33rd and 66th percentile and by ethnic group, while adjusting for degree of obesity. The prevalence of the MS significantly increased across increasing HOMA-IR tertiles (P for trend o0.001) after adjustment for race and obesity group.
The relationship between pro-and anti-inflammatory markers and insulin resistance was examined. CRP levels were significantly related to the degree of obesity (Po0.001) and tended to rise with the number of components of the MS in this cohort. Adiponectin levels decreased with increasing obesity. When stratified by obesity group and HOMA-IR tertiles, adiponectin levels were significantly affected by the obesity category (P ¼ 0.04) and the HOMA-IR tertile (P ¼ 0.005), indicating that adiponectin was lowest in the most resistant individuals. After stratification by obesity group, the effect of HOMA-IR was evident in the moderately obese where the most insulin resistant subjects had significantly lower adiponectin compared to those in the middle and low tertiles (P Holm ¼ 0.04 and 0.002 respectively). In contrast, adiponectin levels did not significantly vary by HOMA-IR tertile in the severely obese group. Adiponectin levels negatively correlated with CRP levels (R ¼ À0.18, P ¼ 0.005). IL-6 levels rose significantly with the degree of obesity. IL-6 had a strong relation with CRP levels (R ¼ 0.37, Po0.0001) but no significant relation to HOMA-IR. The relation of IL-6 and CRP remained significant after adjustment for BMI-Z score (R ¼ 0.29, Po0.0001).
Conclusions
These findings suggest that intramyocellular and intraabdominal lipid accumulation are strongly associated with the development of severe insulin resistance that predates the clinical onset of type 2 diabetes in obese youngsters.
The prevalence of the MS is high in obese youth, and increases with worsening obesity and insulin resistance. Biomarkers of adverse cardiovascular outcomes are already present in these youngsters.
